Net revenue was stable at BRL 475 million in 3Q25, with strong Aesthetics growth and improved gross margin for the eighth consecutive quarter. Net income surged 52% year-over-year, driven by Prothya divestment gains, while CAPEX and R&D investments increased significantly.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.